Search - tctmd.com

Displaying 61 - 72 of 72

Sort: Relevancy | Date

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

June 18, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

L.A. McKeown

March 05, 2015

News Daily News

Substantial BP Reductions Appear to Lower Stroke Risk Safely in CAD Patients

Todd Neale

November 02, 2014

News Conference News ESC 2014

Post-Acute MI Survival Improving for Elderly Patients in France

Todd Neale

August 30, 2014

News Daily News

Registry Data Support Efficacy of Revascularization in Stable Patients

March 27, 2014

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

News Daily News

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

L.A. McKeown

March 05, 2012

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

Advertisement

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

Analysis of SYNTAX Patients Documents Underuse of OMT

Substantial BP Reductions Appear to Lower Stroke Risk Safely in CAD Patients

Post-Acute MI Survival Improving for Elderly Patients in France

Registry Data Support Efficacy of Revascularization in Stable Patients

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content